Jason Duncan was Appointed as General Counsel and Secretary at Albireo-Pharma

Date of management change: June 18, 2018 

What Happened?

Boston, -based Albireo-Pharma Appointed Jason Duncan as General Counsel and Secretary

 

About the Company

Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo`s lead product candidate, A4250, is directed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in its initial target indication, progressive familial intrahepatic cholestasis. Albireo`s clinical pipeline also includes two Phase 2 product candidates. Albireo`s elobixibat, approved in Japan for the treatment of chronic constipation, is the first ileal bile acid transporter (IBAT) inhibitor approved anywhere in the world. Albireo was spun out from AstraZeneca in 2008. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden.

 

About the Person

Jason Duncan is General Counsel and Secretary at Albireo Pharma. Previously, Jason held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Lease Shari, Connaughton Kevin, Finch Norman, Rosenthal Ted, Guan Maggie, Murphy Sheriann, Mendola Michael, Grinnan Richard, Morrison Todd, Weitzel Harry, Buchanan Mary Beth

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.